743 Feasibility and the efficacy of RRSO combined with simultaneous mastectomy and breast reconstruction in BRCA 1–2 patients
Giulio Bonaldo(University of Padua), Carlo Saccardi(University of Padua), Maria Cristina Toffanin(Istituto Oncologico Veneto), M Marchetti(University of Padua), Silvia Michieletto(Istituto Oncologico Veneto), Roberto Tozzi(University of Padua), Fernando A. Bozza(D’Or Institute for Research and Education), Marco Noventa(University of Padua), Sofia Tosatto(University of Padua), Tania Saibene(Istituti di Ricovero e Cura a Carattere Scientifico), Giulia Spagnol(University of Padua)
Cited by 0
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527
A Central Role for Free Heme in the Pathogenesis of Severe Sepsis
|Science Translational Medicine|2010|492